| CAS No. | 2192215-81-7 |
|---|---|
| MDL No. | N/A |
| MF | C22H27N5O4S |
| MW | 457.50 |
| InChI Key | YOZLVAFWYLSRRN-VZXYPILPSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 25 mg | 95% | $368 | In Stock | |
| 50 mg | 95% | $587 | In Stock | |
| 100 mg | 95% | $939 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Ritlecitinib tosylate is an organosulfonate salt formed from equimolar amounts of ritlecitinib and 4-toluenesulfonic acid. It is a kinase inhibitor developed by Pfizer for the treatment of severe alopecia areata in adults and adolescents 12 years and older. It functions as an anti-inflammatory, non-specific protein-tyrosine kinase inhibitor, immunosuppressive agent, antirheumatic drug, and dermatologic drug. It contains ritlecitinib(1+).
| CAS No. | 2192215-81-7 |
|---|---|
| Product Name | Ritlecitinib tosylate |
